Skip to main content
Beijing SL Pharmaceutical Co., Ltd. logo

Beijing SL Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002038 ISIN · CNE000001L31 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,472 across all filing types
Latest filing 2013-04-17 Annual Report
Country CN China
Listing Shenzhen Stock Exchange 002038

About Beijing SL Pharmaceutical Co., Ltd.

https://www.slpharm.com.cn

Beijing SL Pharmaceutical Co., Ltd. specializes in the research, development, manufacturing, and commercialization of pharmaceutical products. The company focuses on several therapeutic areas, including cardiovascular and cerebrovascular diseases, oncology, and infectious diseases. Its product portfolio features a range of chemical drugs and active pharmaceutical ingredients (APIs), with key offerings such as clopidogrel bisulfate and amlodipine besylate. Operating with advanced production facilities that adhere to international Good Manufacturing Practice (GMP) standards, the company emphasizes technological innovation and quality control. The organization serves both domestic and international markets, leveraging its integrated R&D platform to develop generic medications and innovative formulations aimed at improving patient outcomes.

Recent filings

Filing Released Lang Actions
2012年年度报告摘要
Annual Report Classification · 95% confidence The document is titled as the "2012 年度报告摘要" which translates to "2012 Annual Report Summary". It contains detailed financial data for the year 2012, including revenue, net profit, earnings per share, and asset information. It also includes management discussion and analysis of the company's operations and business segments for the year. The document is over 6,000 characters, indicating it is substantive and not merely an announcement or a brief summary. The content aligns with the characteristics of an Annual Report, which covers company activity and full financial performance for the fiscal year. Therefore, the document should be classified as an Annual Report (10-K). FY 2012
2013-04-17 Chinese
关于使用自有资金进行短期低风险投资事项的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by Beijing Shuanglu Pharmaceutical Co., Ltd. regarding the use of its own funds for short-term low-risk investments. It details the investment purpose, amount, approval procedures, impact on the company, risk control measures, and includes independent directors' and supervisory board opinions. The document is a formal announcement of a corporate financing-related decision but does not contain financial statements or detailed financial results. It is not a full financial report, earnings release, or management report. It is also not a regulatory filing or certification. The content fits best under Capital/Financing Update (CAP) as it relates to the company's financing activities and capital management decisions.
2013-04-17 Chinese
2013年第一季度报告全文
Interim / Quarterly Report Classification · 95% confidence The document is titled "北京双鹭药业股份有限公司 2013 年第一季度报告全文" which translates to "Beijing SL Pharmaceutical Co., Ltd. 2013 First Quarter Report Full Text." It contains detailed financial data for the first quarter of 2013, including income statements, balance sheets, cash flow statements, shareholder information, and management commentary on financial performance and changes. The document includes comprehensive financial statements and analysis for a period shorter than a full fiscal year (quarterly). This matches the definition of an Interim / Quarterly Report (IR). The document is lengthy (15,000 characters) and contains substantive financial data, not just an announcement or certification. Therefore, the correct classification is IR with high confidence. Q1 2013
2013-04-17 Chinese
关于召开2012年度股东大会的通知
AGM Information Classification · 95% confidence The document is a detailed notice about the convening of the 2012 Annual General Meeting (AGM) of Beijing SL Pharmaceutical Co., Ltd. It includes information about the meeting date, voting procedures (both onsite and online), agenda items to be discussed and voted on, registration details, and proxy forms. The document does not contain the actual annual report or financial statements but rather the announcement and procedural details for the AGM. The presence of agenda items such as the 2012 annual report and financial statements indicates this is a meeting notice rather than the report itself. The document length is about 6983 characters, which is consistent with a detailed meeting notice rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R).
2013-04-17 Chinese
2012年年度审计报告
Audit Report / Information Classification · 95% confidence The document is titled as an audit report (审计报告) for Beijing Shuanglu Pharmaceutical Co., Ltd. It includes detailed financial statements such as consolidated and parent company balance sheets, profit and loss statements, cash flow statements, and changes in equity for the fiscal year from January 1, 2012, to December 31, 2012. The presence of an auditor's opinion, detailed financial data, and notes to the financial statements indicates this is a standalone audit report rather than a full annual report or a brief announcement. The document length is substantial (15,000 characters), and it contains comprehensive financial data and audit opinions, which aligns with the definition of an Audit Report / Information (AR). FY 2012
2013-04-17 Chinese
关于第二大股东新乡白鹭化纤集团有限责任公司股权质押的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding the pledge of shares by the company's second largest shareholder. It details the number of shares pledged, the dates of pledge registration, and the related loan guarantees. There is no financial report, earnings data, or management discussion. The document is a regulatory announcement about share pledge status, which fits the category of Regulatory Filings (RNS) as it does not fit into more specific categories like Major Shareholding Notification (MRQ) or Transaction in Own Shares (POS) because it concerns pledge status rather than ownership changes or share transactions by the company itself.
2013-03-06 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.